Please login to the form below
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Indication
A medical condition which makes a particular drug treatment or procedure advisable in line with the Product License. Drug approvals for specific indications are controlled in most countries and jurisdictions by a licensing body, including the Food and Drug Administration (FDA) in the US and the European Medical Association (EMA) in the EU.
See also:
Food And Drug Administration (FDA)
License (product)
Related terms
Institutional review board (IRB) - pharmacoeconomics, Diagnostic trials, New Drug Application (NDA), Disease awareness marketing, Treatment Investigational New Drug (IND), Open-label trial, Product pipeline, Randomised trial, Food And Drug Administration (FDA), Effectiveness, Phase II trials, Newspaper Licensing Agency (NLA), Dose-ranging trial, Interventions - clinical, Phase III trials,
COVID-19 Updates and Daily News
Featured jobs
-
Senior Account Manager
-
Competitive salary offered
-
CEO Pricing & Market Access, UK
-
Six figure salary
-
Omnichannel Strategy Consultant
-
Competitive Salary
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- Biosimilars boosted by FDA's landmark ruling for Boehringer’s Cyltezo
- US demand for COVID-19 antibody treatments rising fast
- EU “still interested” in Valneva COVID vaccine despite UK snub
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- Biogen's ALS drug tofersen misses phase 3 endpoint
- Pfizer-BioNTech booster offers 95.6% efficacy against COVID-19
- US COVID-19 booster programme expanded
- The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
- Mind the Gap – Challenging Immunisation Apathy and Misinformation
- Towards Better HCP Engagement – An Email Masterclass
- An Introduction to HES Data from Meditrends
No results were found
